Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Fifita

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2019
Theme 3 In vitro experimental modelsShu Yang, Sharlynn Wu, Jennifer Fifita, et al.
Human Molecular Genetics|May 21, 2026
Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron diseaseHiu Chuen Lok, Carol Dobson-Stone, Marianne Hallupp, et al.
Acta Neuropathologica|March 5, 2025
Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine modelAmr H Abdeen, Benjamin G Trist, Sara Nikseresht, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 10, 2023
Clinical testing panels for ALS: global distribution, consistency, and challengesAllison A Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2019
Theme 3 In vitro experimental modelsShu Yang, Sharlynn Wu, Jennifer Fifita, et al.
Human Molecular Genetics|May 21, 2026
Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron diseaseHiu Chuen Lok, Carol Dobson-Stone, Marianne Hallupp, et al.
Acta Neuropathologica|March 5, 2025
Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine modelAmr H Abdeen, Benjamin G Trist, Sara Nikseresht, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 10, 2023
Clinical testing panels for ALS: global distribution, consistency, and challengesAllison A Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, et al.
Pageof 1